These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3332704)

  • 21. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriological and pharmacokinetic properties of new oral cephalosporin compounds].
    Mössner G; Bürker U; Egetmeyer KA; Mauer H
    Arzneimittelforschung; 1969 Dec; 19(12):1949-55. PubMed ID: 4986146
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1980 Apr; 17(4):583-90. PubMed ID: 6967294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of bacterial resistance to the third generation cephalosporins and their clinical use.
    Kolár M; Látal T; Hájek V
    J Chemother; 1999 Aug; 11(4):260-5. PubMed ID: 10465127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro selection of beta-lactam resistance by exposure to second, third, and fourth generation cephalosporins.
    Murray PR
    Chemioterapia; 1985 Feb; 4(1):78-82. PubMed ID: 3872726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P; Gaillard JL
    Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria.
    Oni AA; Bakare RA; Arowojolu AO; Kehinde Toki RA; Fasina NA
    Afr J Med Med Sci; 2001; 30(1-2):35-7. PubMed ID: 14510147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of BMY-28142, a new cephalosporin.
    Norden CW; Neiderriter K
    Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
    Cheng WC; Xiang XD; Chen P; Zan JN
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):567-9. PubMed ID: 12516407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance Group.
    Fuchs PC; Barry AL; Brown SD
    Diagn Microbiol Infect Dis; 1996 Apr; 24(4):213-9. PubMed ID: 8831036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of the in-vitro activity of cefepime and other cephalosporins.
    Lim VK; Halijah MY
    Malays J Pathol; 1993 Jun; 15(1):65-8. PubMed ID: 8277793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Concept of class in relation to first-generation cephalosporins].
    De Toffoli A; Fantin B; Vechiet D
    Quad Sclavo Diagn; 1984 Jun; 20(2):181-6. PubMed ID: 6441962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values].
    Cluzel M; Chanal M; Sirot D; Sirot J; Cluzel R
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):473-6. PubMed ID: 3937122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
    Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
    G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ
    Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent status of bacterial sensitivities to various antibiotics.
    Fearn J; Ahmed SI
    J Pak Med Assoc; 1976 Nov; 26(11):220-3. PubMed ID: 829148
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies of susceptibility to antibiotics in strains of E. coli isolated from urine in the years 1986-1990].
    Szeniawska A; Jasińska B; Mazur E; Ligeza J; Fota-Markowska H; Kunkiewicz A; Niedźwiadek J
    Ann Univ Mariae Curie Sklodowska Med; 1992; 47():127-31. PubMed ID: 1365783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.